Zytiga and Prostatic specific antigen increased - a phase IV clinical study of FDA data
Summary:
Prostatic specific antigen increased is reported as a side effect among people who take Zytiga (abiraterone acetate), especially for people who are 60+ old, have been taking the drug for 1 - 6 months also take Xtandi, and have Prostate cancer.
The phase IV clinical study analyzes which people have Prostatic specific antigen increased when taking Zytiga. It is created by eHealthMe based on reports of 29,870 people who have side effects when taking Zytiga from the FDA, and is updated regularly.
What is Zytiga?
Zytiga has active ingredients of abiraterone acetate. It is often used in prostate cancer metastatic. eHealthMe is studying from 29,928 Zytiga users. Check the latest studies of Zytiga.
What is Prostatic specific antigen increased?
Prostatic specific antigen increased is found to be associated with 717 drugs and 688 conditions by eHealthMe. Check the latest studies of Prostatic specific antigen increased.
29,870 people reported to have side effects when taking Zytiga.
Among them, 1,680 people (5.62%) have Prostatic specific antigen increased.
Among these 1,680 people:
How long have people been on Zytiga when they have Prostatic specific antigen increased? *
What is the age of people who have Prostatic specific antigen increased when taking Zytiga? *
What are other drugs people take besides Zytiga? *
What are other side effects people have besides Prostatic specific antigen increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zytiga and have Prostatic specific antigen increased?
- Check whether Prostatic specific antigen increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zytiga:
- Zytiga (29,928 reports)
Prostatic specific antigen increased treatments and more:
- Prostatic specific antigen increased (16,565 reports)
How severe was Prostatic specific antigen increased and when was it recovered:
Expand to all the drugs that have ingredients of abiraterone acetate:
- Prostatic specific antigen increased and drugs with ingredients of abiraterone acetate (2,271 reports)
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zytiga:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Prostatic specific antigen increased:
- Prostatic specific antigen increased (717 drugs)
Browse all the conditions that are associated with Prostatic specific antigen increased:
- Prostatic specific antigen increased (688 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on abiraterone acetate (the active ingredients of Zytiga) and Zytiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Paracetamol cause Taste - Impaired? - 12 seconds ago
- Drug interactions of Risperdal and Tolterodine - 32 seconds ago
- Could Docetaxel cause Hypothyroidism? - 36 seconds ago
- Drug interactions of Euthyrox and Haloperidol - a minute ago
- Weight Loss and Breast Lump - 2 minutes ago
- Could Misoprostol cause Erythema Multiforme? - 2 minutes ago
- Opana Er vs. Tapentadol Hydrochloride, side effect and effectiveness comparison - 2 minutes ago
- Could Nexavar cause Conjunctivitis Exacerbated? - 2 minutes ago
- Drug interactions of Bumetanide and Pentacarinat - 2 minutes ago
- Aplasia Pure Red Cell and Pleural Effusion - 2 minutes ago